Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

endocrine term 2 quiz 2 - julia's notes > regulation of ca and PO4 metabolism - chapter 9 > Flashcards

regulation of ca and PO4 metabolism - chapter 9 Flashcards

1
Q

normal total ca concentration in blood

A

about 10 mg/mL
40% bound to plasma proteins
60% not protein-bound - ultrafilterable
- some complexed to anions but most free - 50% free - only form that’s biologically active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hypocalcemia symptoms

A 
spontaneous twitching
muscle cramps
tingling
numbness
chvostek sign and trousseau sign
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

chvostek sign

A

twitching of the facial muscles elicited by tapping on the facial nerve
used to diagnose hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

trousseau sign

A

carpopedal spasm upon inflation of a blood pressure cuff

used to detect hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

low extracellular ca causes:

A

1: increased excitability of excitable cells => lower threshold potential, less inward current needed to depolarize => tingling and numbness and spontaneous muscle twitches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hypercalcemia symptoms

A 
constipation
polyuria
polydipsia
neurologic signs of hyporeflexia
lethargy
coma 
death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

changes in anion concentration on ca concentration

A

change the fraction of ca complexed with anions
if plasma phosphate concentration increases => fraction of ca that is complexed increases => decreased ionized ca concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

acidemia

A

excess H+ in blood => more H+ bound to albumin => fewer sites for Ca => increase in free ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

alkalemia

A

deficit of H+ in blood => less H+ bound to albumin => more sites for Ca to bind => hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

vitamin D,1,25-dihydroxycholecalciferol

A

stimulates absorption of Ca in GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

chief cells of parathyroid gland

A

synthesize and secrete PTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PTH

A

secreted by chief cells of parathyroid gland
single-chain with 84 AA
biologic activity resides in N-terminal 34 AA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

synthesis of PTH

A

1: synthesized as preproPTH on ribosomes (115 AA)
2: 25 AA signal sequence cleaved off => 90 AA pro-PTH
3: pro-PTH transported to golgi
4: 6 AA cleaved => PTH
5: packaged into secretory granules for release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

short-term regulation of PTH secretion

A

by plasma ionized ca concentration
secreted at basal level when ca levels normal
reaches maximal rates when ca levels at 7.5
response within seconds
mg levels also regulate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mechanism of PTH secretion

A

1: parathyroid cell membrane has Ca sensing receptors linked via Gq to phospholipase C
2: extracellular ca concentration increased
3: Ca binds to receptor
4: phospholipase C activated
5: increased levels of IP3/Ca2+
6: inhibits PTH secretion

if amounts of ca binding receptor decrease, inhibition of PTH secretion is decreased so more PTH secreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

long-term regulation of PTH secretion

A

chronic changes in plasma Ca concentration alter transcription of gene for preproPTH, synthesis and storage of PTH, and growth of parathyroid glands
therefore, chronic hypocalcemia => secondary hyperparathyroidism => increased synthesis and storage of pTH and hyperplasia of parathyroid glands
chronic hypercalcemia => decreased synthesis and storage of PTH, increased breakdown of PTH, and release of inactive PTH fragments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

secondary hyperparathyroidism

A

due to chronic hypocalcemia
increased synthesis and storage of PTH
hyperplasia of parathyroid glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mg on PTH secretion

A

hypomagnesia stimulates PTH
hypermagnesia inhibits
except with severe hypomagnesia associated with chronic Mg depletion (alcoholism) => inhibition of PTH synthesis, storage, secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

mechanisms of action of PTH

A

on bone and kidney, direct, mediated by cAMP

on intestine, indirect via activation of vitamin d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

mechanism of PTH action on kidney

A

1: PTH binds receptor
2: receptor coupled to adenylyl cyclase via Gs protein
3: adenylyl cyclase catalyzes conversion of ATP to cAMP
4: cAMP activates protein kinases
5: protein kinases phosphorylate intracellular proteins
6: these proteins inhibit Na/phosphate cotransport at luminal membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

PTH on bone

A

increased bone resorption
1: PTH receptors on osteoblasts, not osteoclasts - direct action on osteoblasts initially creates increase in bone formation
2: long-term, causes increase in bone resorption via indirect action on osteoclasts mediated by cytokines released by osteoblasts => release of both Ca and P to ECF - also release of hydroxyproline, which is excreted in urine
not enough to explain entire increase in ca due to PTH, though - other mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PTH on kidney

A

decreased phosphate reabsorption (phosphaturia)
increased ca reabsorption
increased urinary cAMP
1: inhibits phosphate reabsorption by inhibiting Na-phosphate cotransport in PCT => phosphaturia - prevents phosphate released along with ca by resorption of bone from complexing with ca in ECF
cAMP generated in PT cells also excreted in urine
2: stimulates Ca reabsorption - on DCT

23
Q

actions of PTH of intestine

A

increase ca absorption (indirectly via 1,25-dihydroxycholechalciferol)
stimulates renal 1alpha-hydroxylase => conversion of 25-hydroxycholecalciferol to active form = 1,25-dihyroxycholecaliferol => stimulates intestinal ca absorption

24
Q

hyperparathyroidism

A

rater of bone resorption elevated => increased serum Ca concentration

25
Q

1alpha-hydroxylase

A

renal enxyme that is stimulated by PTH
converts 25-hydroxycholecalciferol to active form 1,25-dihydroxycholecalciferl
(activates vitamin D)
therefore stimulates intestinal ca absorption

26
Q

primary hyperparathyroidism (table)

A

increased PTH
increased 1,25-dihydroxyholecalciferol (because of PTH’s effect on 1alpha-hydroxylase)
increased bone resorption
increase urine phosphate concentration adn ca
increase urine cAMP
increased serum ca
decreased serum phos

27
Q

surgical hypoparathyroidsm (table)

A 
decreased PTH
decreased 1,25-dihydroxyholecalciferol (because of PTH's effect on 1alpha-hydroxylase)
decreased bone resorption
decrease urine phosphate concentration
decreased urine cAMP
decreased serum ca
increased serum phos
28
Q

pseudohypoparathyroidism (table)

A 
increased PTH
decreased 1,25-dihydroxyholecalciferol (because of PTH's effect on 1alpha-hydroxylase)
decreased bone resorption (defective Gs)
decrease urine phosphate concentration
decrease urine cAMP
decreased serum ca
increased serum phos
29
Q

humoral hypercalcemia of malignancy (increase PTH-rp) (table)

A 
decrease PTH
increases 1,25-dihydroxyholecalciferol 
increase bone resoprtion
increase urine posphate
increase urine ca because of high filtered load
increase urine cAMP
increase serum ca
decrease serum phos
30
Q

chronic renal failure (table)

A

increase PTH (secondary)
decrease 1,25-dihydroxyholecalciferol
osteomalacia due to decreased 1,25-dihydroxyholecalciferol
increased bone resorption due to increased PTH
decreased urine phosphate due to decreased GFR
decreased serum ca due to decreased 1,25-dihydroxyholecalciferol
decreased serum phos due to decreased urine phos

31
Q

primary hyperparathyroidism

A

most commonly caused by parathyroid adenomas => secretion of excessive amounts of PTH
increased PTH
hypercalcemia due to increased bone resorption, increased renal ca reabsorption and increased intestinal ca absorption
hypophosphatemia due to decreased renal phosphate reabsorption and phosphaturia
get “stones, bones, and groans” = stones from hypercalcemia, bones from increased bone resorption, groans from constipation
treat with parathyroidectomy

32
Q

secondary hyperparathyroidism

A

parathyroid glands are normal but are stimulated to secrete excess PTH secondary to hypocalcemia - can be due to vitamin D deficiency or chronic renal failure
blood levels of ca low or normal but never high
circulating PTH levels elevated

33
Q

hypoparathyroidism

A

inadvertent consequence of thyroid surgery or parathyroid surgery
can also be autoimmune or congenital
low circulating pTH, hopcalcemia due to decreased bone resorption, decreased renal Ca reabsorption and decreased intestinal ca absorption
hyperphosphatemia due to increased phosphate reabsorption
treat with oral ca supplement and active form of vitamin D

34
Q

pseudohypoparathyroidism - albright’s hereditary osteodystrophy

A

hypocalcemia, hyperphosphatemia, short stature, short neck, obesity, subcuateneous calcification, shortened fourth metatarsals and metacarpals
administration of endogenous PTH produces no phosphaturic response and no increase in cAMP
inherited autosomal dominant disorder in which Gs protein for PTH in kidney and bone is defective

35
Q

humoral hypercalcemia of malignancy

A

when malignant tumors (lung, breast) secrete PTH-related peptide (PTH-rp) = structurally homogenous to PTH - has all actions of PTH
=> hypercalcemia and hypophosphatemia despite low circulating levels of PTH
treat with furosemide and etridronate

36
Q

furosemide

A

used to treat humoral hypercalcemia of malignancy

inhibits renal ca reabsorption and increases ca excretion

37
Q

etidronate

A

used to treat humoral hypercalcemia of malignancy

inhibits bone resorption

38
Q

familial hypocalciuric hypercalcemia (FHH)

A

autosomal dominiant
decreased urinary ca excretion
increased serum ca concentration
due to inactivation mutations of the ca sensing receptors in parathyroid glands adn parallele recptors in the thick AL of kidney
defective renal receptors => high serum ca concentration incorrectly sensed as normal so PTH secretion not inhibited as it should be

39
Q

clinical presentation of primary hyperthyroidism

A 
generalized weakness
easy fatigability
loss of appetite
occasional vomiting
higher urine output
unusually thirsty
lab tests show:
hypercalcemia and hypophosphatemia and phosphaturia, elevated PTH
40
Q

calcitonin

A

secreted by parafollicular cells of thyroid gland

straight-chain peptide with 32 AA

41
Q

stimuli for calcitonin release

A

increased plasma Ca

42
Q

actions of calcitonin

A

inhibits osteoclastic bone resorption => decreased plasma ca concentration
doesn’t participate in minute-to-minute regulation

43
Q

vitamin D versus PTH

A

PTH maintains plasma ca concentration - actions coordinated to increase ionized ca concentration toward normal
vitamin D - promotes mineralization of new bone - actions coordinate to increase both ca and phosphate concentrations in plasma so they can be used in bone

44
Q

synthesis of vitamin D

A

1a: 7-dehydrocholesterol is converted in the skin by UV light to cholecalciferol
1b: cholecalciferol is acquired through dietary intake
2: liver converts cholecalcifero to 25-OH-cholecalciferol - in ER, requires NADPH, O2, Mg2+ but not cytochrome P450
3: bound to an alpha-globulin in plasma
4a: 25-OH-cholecalciferol is converted in kidney to 1,25-(OH)2-cholecalciferol by 1alpha-hydroxylase
4b: 25-OH-cholecalciferol is converted to 24,25-(OH2-cholecalciferol (inactive)

45
Q

1alpha-hydroxylase

A

in kidney mitochondria
requires NADPH, O2, Mg, and cytochrome P450
converts 25-OH-cholecalciferol to active form = 1,25-(OH)2-cholecalciferol
activated by:
1: decreased ca
2: increased PTH
3: decreased phosphate

46
Q

regulation of vitamin D synthesis

A

can go to step 4a or 4b depending on status of ca in body - when sufficient, 4b

47
Q

actions of vitamin D on intestine

A

increases both ca and phosphate absorption

induces synthesis of vitamin-d dependent ca binding protein = calbindin D-28 D

48
Q

calbindin D-28 K

A

cytosolic protein in intestine
synthesis stimulated by vitamin D
binds four ca ions
exact role uncertain

49
Q

mechanism of intestinal ca absorption

A

1: ca diffuses from the lumen into the cell, down its electrochemical gradient
2: ca is bound to calbindin D-28K
3: ca is pumped across the basolateral membrane by ca atpase

50
Q

actions of vitamin D in kidney

A

parallel to actions on intestine
stimulates ca and p reabsorption
(PTH stimulates ca reabsorption but INHIBITS p reabsorption)

51
Q

actions of vitamin D in bone

A

acts synergistically with PTH to stimulate osteoclast activity and bone resorption
allows for mineralized old bone to be resorbed to provide more ca and p to ecf so that new bone can be made

52
Q

rickets

A

due to vitamin d deficiency in children
not enough ca and p to mineralize bone
growth failure and skeletal deformities

53
Q

osteomalacia

A

due to vitamin d deficiency in adults

new bone fails to mineralize, resulting in bending and softening of weight-bearing bones

54
Q

vitamin d resistance

A

when kidney unable to produce ative metabolite (1,25…)

can be due to congenital absence of 1alpha-hydroxylase or chronic renal failure

endocrine term 2 quiz 2 - julia's notes (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions